These are just a few of the more common side effects reported by people who took Humira in clinical trials: headache injection site reactions rash upper respiratory infections, such as the common ...

According to Sanofi and Dren Bio, DR-0201 is a new drug candidate expected to be effective in treating a group of B-cell-mediated autoimmune diseases, including lupus, which causes rashes all over ...

In addition, the location of the rash can help identify the culprit ... including Enbrel (etanercept), Remicade (infliximab), Humira (adalimumab), Tremfiya (guselkumab), and Cosentyx (secukinumab ...

In addition, the location of the rash can help identify the culprit ... including Enbrel (etanercept), Remicade (infliximab), Humira (adalimumab), Tremfiya (guselkumab), and Cosentyx (secukinumab) ...

This may include pain, redness, swelling, itch, bruise, or rash. You may have an allergic reaction to the ... There may be side effects, but the benefits usually outweigh the risks. Humira, Cimzia, ...

Novartis' Sandoz division has filed its biosimilar of Humira in the US, aiming to take a share of its multi-billion dollar revenues once its patent expires. The generics and biosimilars arm of ...

Poison oak rash is an allergic reaction to the leaves or stems of the western poison oak plant (Toxicodendron diversilobum). Home remedies and medical treatments can help manage symptoms.

Rashes can be maddeningly itchy, no matter what the cause. Doctors are likely to prescribe creams, lotions, or antihistamines for relief. They may also suggest cold compresses or other home remedies.

Tuberculosis (TB) is a bacterial infection that usually affects the lungs but can spread to other parts of the body, including the skin. Once it reaches the skin, TB can cause a variety of lesions ...

This week has seen the launch of new and lower-priced biosimilars to AbbVie’s Humira (adalimumab), many months after Amgen’s Amjevita (adalimumab-atto) was released in the US in January.

We don’t know the ending yet.” Features of DRESS, Shenoi said, include onset 2-8 weeks after drug initiation; generalized maculopapular rash, typically without blisters; and presence of ...